Zurcher Kantonalbank (Zurich Cantonalbank) Arcus Biosciences, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$34.1 Billion
Q4 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 33,224 shares of RCUS stock, worth $397,691. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,224

Previous 30,781 7.94%

Holding current value

$397,691

Previous $470,000 5.11%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$14.28 - $18.44 $34,886 - $45,048	2,443 Added 7.94%	33,224 $494,000
Q3 2024 Nov 07, 2024	BUY	$13.69 - $18.01 $11,540 - $15,182	843 Added 2.82%	30,781 $470,000
Q2 2024 Jul 29, 2024	SELL	$14.59 - $18.48 $4,479 - $5,673	-307 Reduced 1.02%	29,938 $455,000
Q1 2024 Apr 25, 2024	BUY	$14.83 - $20.18 $168,498 - $229,285	11,362 Added 60.17%	30,245 $571,000
Q4 2023 Jan 30, 2024	BUY	$13.43 - $19.63 $69,177 - $101,114	5,151 Added 37.51%	18,883 $360,000
Q3 2023 Oct 25, 2023	BUY	$17.62 - $23.54 $40,332 - $53,883	2,289 Added 20.0%	13,732 $246,000
Q2 2023 Aug 07, 2023	BUY	$16.97 - $22.03 $2,715 - $3,524	160 Added 1.42%	11,443 $232,000
Q1 2023 May 08, 2023	SELL	$15.96 - $23.15 $1,771 - $2,569	-111 Reduced 0.97%	11,283 $205,000
Q4 2022 Feb 01, 2023	SELL	$19.7 - $35.71 $985 - $1,785	-50 Reduced 0.44%	11,394 $235,000
Q3 2022 Nov 09, 2022	SELL	$23.23 - $30.07 $9,640 - $12,479	-415 Reduced 3.5%	11,444 $299,000
Q2 2022 Aug 09, 2022	SELL	$17.23 - $37.73 $7,770 - $17,016	-451 Reduced 3.66%	11,859 $301,000
Q1 2022 Apr 21, 2022	SELL	$28.92 - $41.83 $6,882 - $9,955	-238 Reduced 1.9%	12,310 $389,000
Q4 2021 Feb 01, 2022	BUY	$31.38 - $48.47 $1,380 - $2,132	44 Added 0.35%	12,548 $508,000
Q3 2021 Nov 15, 2021	SELL	$26.93 - $37.68 $4,847 - $6,782	-180 Reduced 1.42%	12,504 $436,000
Q2 2021 Jul 30, 2021	BUY	$22.75 - $35.77 $8,827 - $13,878	388 Added 3.16%	12,684 $348,000
Q1 2021 May 03, 2021	BUY	$26.16 - $41.39 $117,693 - $186,213	4,499 Added 57.7%	12,296 $345,000
Q4 2020 Jan 28, 2021	BUY	$17.0 - $32.36 $78,863 - $150,118	4,639 Added 146.9%	7,797 $202,000
Q3 2020 Nov 06, 2020	BUY	$17.14 - $25.47 $29,377 - $43,655	1,714 Added 118.7%	3,158 $54,000
Q2 2020 Jul 28, 2020	BUY	$13.97 - $36.56 $20,172 - $52,792	1,444 New	1,444 $36,000

Others Institutions Holding RCUS

# of Institutions

201

Shares Held

51.1M

Call Options Held

266K

Put Options Held

171K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $864M
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Arcus Biosciences, Inc. Transaction History